CIK 0001297184 · Large accelerated filer
Amphastar Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 330702205
- Phone
- 909-980-9484
- Business address
- 11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
- 4 Open-market sale Director sold 3,772 shares at $13.95 ($52,606)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes President gave up 987 shares (to pay taxes)
- 4 Shares withheld for taxes President gave up 770 shares (to pay taxes)
- 4 Option exercise CEO & Chief Scientific Officer acquired 16,962 shares (option exercise)
- 4 Open-market sale Director sold 14,500 shares at an average $14.67 ($212,779)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Director sold 7,692 shares at $17.41 ($133,923)
- 4 Open-market sale Director sold 7,692 shares at $17.41 ($133,900)
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 4 Shares withheld for taxes President gave up 9,289 shares (to pay taxes)
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3 Offering Registration Statement
- 8-K Event Other events
- 4 Open-market sale EVP, Production sold 1,000 shares at $16.48 ($16,480)
- 4 Shares withheld for taxes Former Officer gave up 1,639 shares (to pay taxes)
Page 43 of 48 · 958 filings